Levocabastine Hydrochloride/Mometasone furoate

盐酸左卡巴斯汀/莫米松糠酸酯

Report date: 2022/07/04 19:38:02

Base Information

Drug NameLevocabastine Hydrochloride/Mometasone furoate
Drug Alias Name盐酸左卡巴斯汀+莫米松糠酸酯Levocabastine Hydrochloride+Mometasone furoateMometasone furoate+Levocabastine Hydrochloride莫米松糠酸酯+盐酸左卡巴斯汀Mometasone furoate/Levocabastine Hydrochloride +[7] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionHistamine H1 receptor antagonistsGlucocorticoid receptor agonists
TargetsHistamine H1 receptorGlucocorticoid receptor
Therapy Area/IndicationsRhinitis, Allergic, Perennial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes Levocabastine HydrochlorideMometasone furoate
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesChong Kun Dang Pharmaceutical Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChong Kun Dang Pharmaceutical Corp
Active IndicationsN/A
Inactive IndicationsRhinitis, Allergic, Perennial

Other Information

ATC CodeN/A
Related LinksN/A